Abstract
Abstract We performed a randomized, double blind, placebo-controlled trial with blueberry supplementation in older adults with mild cognitive impairment. We measured cognitive performance and parent (unmodified food form) anthocyanins and a suite of flavonoid-based phase 2 metabolites arising from anthocyanins in urine. The blueberry-treated group exhibited improved semantic access (p = 0.01) and visual-spatial memory (p = 0.05), and there was a trend for enhanced speed of processing (p = 0.08). There was no group difference in urinary excretion of total anthocyanins (parent plus metabolite forms) due to an abundance of phase 2 metabolites in both groups. However, parent anthocyanins (less than 0.1% of total) were 100 times greater in the blueberry group and were correlated with neurocognitive benefit. Ongoing blueberry intake introduced in advance of dementia improved cognitive performance, which was correlated specifically with the recent intake of blueberry and an abundance of parent anthocyanins.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
